congestive heart failureelectrocardiogramheart rate variabilityThis study aims to evaluate the effect of heart rate variability (HRV) indices on the New York Heart Association (NYHA) classification of patients with congestive heart failure and to test the effectiveness of different machine learning ...
aclass congestive heart failure 正在翻译,请等待...[translate] a有几家批发古董商。 Some several wholesale the antique dealer.[translate] aFlatten gou rself against the wall wall by using 铺平gou rself反对墙壁墙壁通过使用[translate] a从6月末开始,共一周 From at the end of June start, an altog...
apediatric pneumonia is clinical for common diseases, diseases prevalent. Because the baby is not breathing cycle sound good, it is also the reason why babies die, Once development of disease, and congestive heart failure is extremely easy. 小儿科肺炎为常见病,疾病是临床的流行。 由于婴孩不呼吸周...
Our aim was to study the effect of BAT on levels of the progn... M Halbach,T Hickethier,N Madershahian,... - 《European Heart Journal》 被引量: 0发表: 2013年 Comparative Analysis Between NTproBNP and BNP on the Prediction for Congestive Heart Failure PURPOSE: The BNP (B-type ...
Whereas patients receiving doxazosin and chlortalidone had similar rates of fatal CHD and non-fatal MI, it was found that those taking doxazosin had a higher incidence of congestive heart failure compared with those taking chlortalidone (8.13% vs. 4.45% at 4 years; p < 0.001). ...
beta-Blockers in congestive heart failure: is there a difference between classes?Presents medical correspondence on the effectivity of vasodilating and nonvasodilating beta-blockers. Percent reduction in mortality; Comparison of mortality rate in vasodilating group versus nonvasodilating group.Stello...
The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapydoi:10.1016/S0167-5273(99)00207-7L LiuInternational Journal of Cardiology
Aims/hypothesis Several cardiovascular outcome trials on sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been released recently, including trials enrolling patients with congestive heart failure (CHF) and chronic kidney disease (CKD). Comparisons of the efficacy and safety of SGLT2i, glucagon-...
Several cardiovascular outcome trials on sodium鈥揼lucose cotransporter 2 inhibitors (SGLT2i) have been released recently, including trials enrolling patients with congestive heart failure (CHF) and chronic kidney disease (CKD). Comparisons of the efficacy and safety of SGLT2i, glucagon-like peptide...
1. 310) .Rate of re-infarction,recurrent angina,congestive heart failure increased in patients with risk factors than those of without(P0. 05 or P0. 01) .Conclusion:The aged,diabetes,abnormal QTd、cTnI、CRP and ST-segment depression≥1 mV were risk factors of early risk stratification in ...